New Breakthrough: T-DXd + Pertuzumab in HER2-Positive Breast Cancer | Clinical Trial Results 2025
YouTubeTimeless Moments
New Breakthrough: T-DXd + Pertuzumab in HER2-Positive Breast Cancer | Clinical Trial Results 2025
Discover the latest advancements in HER2-positive advanced breast cancer treatment with the phase III DESTINY-Breast09 trial. This video reviews how T-DXd plus pertuzumab significantly improves progression-free survival compared to traditional therapies. Learn about study details, key findings, and safety profiles from recent clinical research ...
12 hours ago
HER2 Function
【乳癌ステージ４】再発したガンが複数見つかりました
8:54
【乳癌ステージ４】再発したガンが複数見つかりました
YouTubeことびびちゃんねる (乳がん
31.7K views6 days ago
2025 ESMO Bladder Cancer Highlights
26:22
2025 ESMO Bladder Cancer Highlights
YouTubeDana-Farber Cancer Institute
4 views1 day ago
Breaking Up Cancer Proteins: New Ras-PI3Kα Strategy in Clinical Trials
2:57
Breaking Up Cancer Proteins: New Ras-PI3Kα Strategy in Clinical Trials
YouTubeEndless Horizons
7 hours ago
Top videos
Breakthrough in HER2-Positive Breast Cancer Treatment: T-DXd Plus Pertuzumab Shows Promise
6:53
Breakthrough in HER2-Positive Breast Cancer Treatment: T-DXd Plus Pertuzumab Shows Promise
YouTubeTimeless Echoes
12 hours ago
Why Is ER, PR, HER2 Status Important In Breast Cancer Pathology? - Breast Cancer Support Channel
3:56
Why Is ER, PR, HER2 Status Important In Breast Cancer Pathology? - Breast Cancer Support Channel
YouTubeBreast Cancer Support
2 days ago
What Is ER, PR, And HER2 Status On A Breast Cancer Pathology Report? - Breast Cancer Support Channel
4:43
What Is ER, PR, And HER2 Status On A Breast Cancer Pathology Report? - Breast Cancer Support Channel
YouTubeBreast Cancer Support
2 days ago
HER2 Structure
Fabi (Aiom): ‘tumore seno è malattia sociale, necessario supporto psicologico’
3:34
Fabi (Aiom): ‘tumore seno è malattia sociale, necessario supporto psicologico’
YouTubeAdnkronos
2 days ago
Tumore della mammella in stadio precoce, grandi novità in terapia dal congresso ESMO 2025
4:36
Tumore della mammella in stadio precoce, grandi novità in terapia dal congresso ESMO 2025
YouTubePharmaStarTV
3 views2 days ago
주도주 AI 반도체 외국인 기관 계속 판다면? 그 대안은 바이오? 비만치료제 펩트론 디앤디파마텍 올릭스 말고 리가켐바이오 VS 알테오젠 VS 에이비엘바이오 VS SK바이오팜?
34:33
주도주 AI 반도체 외국인 기관 계속 판다면? 그 대안은 바이오? 비만치료제 펩트론 디앤디파마텍 올릭스 말고 리가켐바이오 VS 알테오젠 VS 에이비엘바이오 VS SK바이오팜?
YouTube김지훈의 훈훈한주식
4 days ago